SCHEMBL26912756

SCHEMBL26912756

Cc1ccc(S(=O)(=O)n2ccc3c(NC(=O)OC(C)(C)C)cc(Cl)c(Cl)c32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ PPARD Q03181 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ PDE4A P27815 2/20 0.36
▸ PDE4B Q07343 2/20 0.36
▸ PDE4C Q08493 2/20 0.36
▸ PDE4D Q08499 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ RORC P51449 7/20 0.36
▸ HCRTR1 O43613 1/20 0.35
▸ HCRTR2 O43614 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ HSP90AB1 P08238 1/20 0.35
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26913617 0.90 MEN1 (0.38) MEN1POLBKMT2APPARGPPARD
SCHEMBL26913270 0.86 PPARG (0.43) MEN1KMT2APPARGPPARDPPARA
SCHEMBL30684152 0.83 KMT2A (0.43) MEN1POLBKMT2APPARGPPARD
SCHEMBL26913621 0.76 PPARG (0.41) MEN1KMT2APPARGPPARDPPARA
SCHEMBL26912221 0.76 BRD4 (0.40) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL26913079 0.75 BRD4 (0.36) MEN1KMT2APPARGPPARDPPARA
SCHEMBL26913122 0.74 GLA (0.33) MEN1POLBKMT2APDE4APDE4B
SCHEMBL26912926 0.73 CA1 (0.42) POLBALDH1A1MAPT
SCHEMBL15374350 0.73 MEN1 (0.46) MEN1POLBKMT2APPARGPPARD
SCHEMBL26913295 0.72 CTSL (0.34) GAARORCHSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391786-A1 cGAS INHIBITORS ELI LILLY AND COMPANY 2023-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391786-A1 cGAS INHIBITORS CGAS, STING1, TBK1 MEN1 2408/4885POLB 245/4885KMT2A 4427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback